FNY Investment Advisers’s Imunon IMNN Stock Holding History

FNY Investment Advisers’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-332	Closed	-$35K	–	818
2021 Q4	$35K	Buy	+332	New	+$51.7K	0.02%	277

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FNY Investment Advisers's IMNN Position: Q1 2022 in Review

FNY Investment Advisers sold out of Imunon (IMNN) in Q1 2022, closing a stake of 332 shares — an estimated $35K sold.

FNY Investment Advisers first reported a position in IMNN in Q4 2021 and held it in 1 quarter. The position peaked at $35K in Q4 2021. 23 funds tracked by Wall St. Rank hold IMNN as of Q1 2022.

FNY Investment Advisers reported no remaining Imunon position as of Q1 2022 after selling out during the quarter.
FNY Investment Advisers sold 332 Imunon shares in Q1 2022, an estimated $35K.
FNY Investment Advisers first reported a position in Imunon in Q4 2021 and held it in 1 quarter.
FNY Investment Advisers's Imunon position peaked at $35K in Q4 2021.
23 funds tracked by Wall St. Rank held Imunon as of Q1 2022.

Based on FNY Investment Advisers's 13F filing for Q1 2022, filed 25 Apr 2022.